Sign up to The Irish Times Archive (1859 - 2008)My Account »
Sat 08 Aug 2008No mercy from a sceptical market
ANALYSIS:They've been stung before so traders were quick to savage Elan, writes Dominic Coyle
IRISH DRUG group Elan may have a world class treatment for multiple sclerosis; it may even have prospects for a new approach to Alzheimer's disease but it also has a serious credibility problem in the eyes of the market.
Choose a Subscription type - required
